Law & Medicine

Oral contraception and medical liability


 

References

The prime reason for disallowing a wrongful life action is that life, even if imperfect, is always preferable to non-life. Besides, it will be impossible to assess the quantum of damages, because this necessarily requires placing a monetary worth on human existence.

The seminal case is the 1967 New Jersey decision of Gleitman v. Cosgrove (227 A.2d 689 [N.J. 1967]), but the state’s position has since changed. In Berman v. Allan (404 A.2d 8 [N.J. 1979]), the court allowed damages for maternal emotional distress, though not for medical and other expenses of raising the child.

Overall, the law of wrongful life appears to be increasingly willing to award damages to the mother for the physical, emotional, and financial costs of pregnancy and delivery, but not the cost associated with the normal rearing of a healthy child.

The legal situation is quite different for a lawsuit filed by the child, who in essence is arguing that he/she should not have been born at all. Courts continue to refuse a claim brought by a healthy infant for wrongful life, adopting the reasoning in Berman that the infant has not suffered any damage cognizable at law by being brought into existence. Even an infant with birth disabilities will not prevail in the majority of jurisdictions, with California being a notable exception.

Dr. Tan is emeritus professor of medicine and former adjunct professor of law at the University of Hawaii, and currently directs the St. Francis International Center for Healthcare Ethics in Honolulu. This article is meant to be educational and does not constitute medical, ethical, or legal advice. Some of the articles in this series are adapted from the author’s 2006 book, “Medical Malpractice: Understanding the Law, Managing the Risk,” and his 2012 Halsbury treatise, “Medical Negligence and Professional Misconduct.” For additional information, readers may contact the author at siang@hawaii.edu.

Pages

Recommended Reading

LT4 therapy for SCH may improve pregnancy outcomes
MDedge Endocrinology
Denosumab better at building bone than zoledronic acid
MDedge Endocrinology
New ACOG recommendations encourage exercise during pregnancy
MDedge Endocrinology
Breastfeeding cuts risk of progression from GDM to type 2 diabetes
MDedge Endocrinology
Phone-based intervention helps drain sugary drinks from preschoolers’ diet
MDedge Endocrinology
Diabetes raises the cardiovascular risk higher in women than men
MDedge Endocrinology
AES: Hormonal contraceptives can boost seizures in epileptics
MDedge Endocrinology
One-step gestational diabetes screen not beneficial
MDedge Endocrinology
FDA sheds light on flibanserin approval
MDedge Endocrinology
Hormone treatment associated with better kidney function
MDedge Endocrinology